Literature DB >> 17368478

Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms.

Pamela Rosettani1, Stefan Knapp, Maria-Grazia Vismara, Luisa Rusconi, Alexander D Cameron.   

Abstract

All eukaryotic cellular mRNAs contain a 5' m(7)GpppN cap. In addition to conferring stability to the mRNA, the cap is required for pre-mRNA splicing, nuclear export and translation by providing an anchor point for protein binding. In translation, the interaction between the cap and the eukaryotic initiation factor 4E (eIF4E) is important in the recruitment of the mRNAs to the ribosome. Human 4EHP (h4EHP) is a homologue of eIF4E. Like eIF4E it is able to bind the cap but it appears to play a different cellular role, possibly being involved in the fine-tuning of protein expression levels. Here we use X-ray crystallography and isothermal titration calorimetry (ITC) to investigate further the binding of cap analogues and peptides to h4EHP. m(7)GTP binds to 4EHP 200-fold more weakly than it does to eIF4E with the guanine base sandwiched by a tyrosine and a tryptophan instead of two tryptophan residues as seen in eIF4E. The tyrosine resides on a loop that is longer in h4EHP than in eIF4E. The consequent conformational difference between the proteins allows the tyrosine to mimic the six-membered ring of the tryptophan in eIF4E and adopt an orientation that is similar to that seen for equivalent residues in other non-homologous cap-binding proteins. In the absence of ligand the binding site is incompletely formed with one of the aromatic residues being disordered and the side-chain of the other adopting a novel conformation. A peptide derived from the eIF4E inhibitory protein, 4E-BP1 binds h4EHP 100-fold less strongly than eIF4E but in a similar manner. Overall the data, combined with sequence analyses of 4EHP from evolutionary diverse species, strongly support the hypothesis that 4EHP plays a physiological role utilizing both cap-binding and protein-binding functions but which is distinct from eIF4E.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368478     DOI: 10.1016/j.jmb.2007.02.019

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

Review 1.  Translational control in cellular and developmental processes.

Authors:  Jian Kong; Paul Lasko
Journal:  Nat Rev Genet       Date:  2012-06       Impact factor: 53.242

2.  eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition.

Authors:  Michael J Osborne; Laurent Volpon; Jack A Kornblatt; Biljana Culjkovic-Kraljacic; Aurélie Baguet; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Crystal structure of a minimal eIF4E-Cup complex reveals a general mechanism of eIF4E regulation in translational repression.

Authors:  Kerstin Kinkelin; Katharina Veith; Marlene Grünwald; Fulvia Bono
Journal:  RNA       Date:  2012-07-25       Impact factor: 4.942

4.  Characterization of the Raptor/4E-BP1 interaction by chemical cross-linking coupled with mass spectrometry analysis.

Authors:  Kimberly Coffman; Bing Yang; Jie Lu; Ashley L Tetlow; Emelia Pelliccio; Shan Lu; Da-Chuan Guo; Chun Tang; Meng-Qiu Dong; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

5.  Tristetraprolin Recruits Eukaryotic Initiation Factor 4E2 To Repress Translation of AU-Rich Element-Containing mRNAs.

Authors:  Xianzun Tao; Guangxia Gao
Journal:  Mol Cell Biol       Date:  2015-09-14       Impact factor: 4.272

6.  The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism.

Authors:  Yong Liu; Yongfeng Yang; Jialin Fan; Ruina He; Ming Luo; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2015-02-17       Impact factor: 5.157

7.  A novel 4EHP-GIGYF2 translational repressor complex is essential for mammalian development.

Authors:  Masahiro Morita; Lian Wee Ler; Marc R Fabian; Nadeem Siddiqui; Michael Mullin; Valerie C Henderson; Tommy Alain; Bruno D Fonseca; Galina Karashchuk; Christopher F Bennett; Tomohiro Kabuta; Shinji Higashi; Ola Larsson; Ivan Topisirovic; Robert J Smith; Anne-Claude Gingras; Nahum Sonenberg
Journal:  Mol Cell Biol       Date:  2012-07-02       Impact factor: 4.272

8.  Structural insights into parasite eIF4E binding specificity for m7G and m2,2,7G mRNA caps.

Authors:  Weizhi Liu; Rui Zhao; Craig McFarland; Jeffrey Kieft; Anna Niedzwiecka; Marzena Jankowska-Anyszka; Janusz Stepinski; Edward Darzynkiewicz; David N M Jones; Richard E Davis
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

Review 9.  RNA-modifying proteins as anticancer drug targets.

Authors:  P Ann Boriack-Sjodin; Scott Ribich; Robert A Copeland
Journal:  Nat Rev Drug Discov       Date:  2018-05-18       Impact factor: 84.694

10.  Identification of gemin5 as a novel 7-methylguanosine cap-binding protein.

Authors:  Shelton S Bradrick; Matthias Gromeier
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.